Khosla Ventures

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Ramp is a company that specializes in providing modern solutions for financial operations and enterprise content delivery. Its financial platform includes tools for corporate card management, expense tracking, bill payments, and seamless accounting integrations, aimed at helping organizations optimize their financial tasks and reduce costs. Additionally, Ramp offers advanced video management and delivery software, enabling companies to enhance video content discovery, user engagement, and secure delivery. Its products, such as VideoVerge and AltitudeCDN, leverage innovative technologies like speech-to-text and natural language processing to create rich metadata for video assets, allowing them to be effectively integrated into popular content management systems. Ramp serves a diverse clientele, including prominent media companies and organizations across various industries such as healthcare, finance, and technology. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation.

Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing tools for biological automation, focusing on scalable automation solutions for genetic engineering. Volta Labs operates a platform designed for affordable genomic sample preparation, aimed at revolutionizing genomics research. This platform leverages automation and miniaturization technologies to streamline the creation of biological samples. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs enables biotech organizations to automate complex biological workflows, facilitating advancements in genomics and genetic engineering.

Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.

Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.

Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.

Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Nebula Genomics is a company that focuses on human genome sequencing and health data, aiming to create a comprehensive online marketplace for genomic information. Founded in 2016 by Harvard genomics pioneer George Church and his colleagues, the company is headquartered in San Francisco, California, with additional offices in Boston, Massachusetts. Nebula Genomics utilizes blockchain technology to empower consumers by allowing them to maintain control over their genomic data and receive compensation for its use. The platform aggregates extensive genetic information, enabling researchers to analyze data for accelerated drug development and personalized medicine. The company’s DNA sequencing technology covers all genes, regulatory regions, the Y chromosome, and mitochondrial DNA, facilitating in-depth genetic analysis and variant exploration.

Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.

Digital Alloys develops high-speed, multi-metal additive manufacturing systems that print production quality parts, in almost any metal, at a fraction of the cost of other systems, making metal 3D metal printing economical for a greatly expanded mix of applications. Digital Alloys metal 3D printers have the unique ability to mix multiple metals in a solid part, enabling customers to push the limits of design and create new products with optimized thermal, electrical, magnetic, and mechanical properties. It was formed in January 2017 as a spinout from the NVLabs division of New Valence Robotics, Inc. (NVBOTS). The company is led by an experienced management team, and backed by Khosla Ventures. Digital Alloys is based in Burlington, Massachusetts.

Ten Percent Happier, Inc. is a Boston-based company that offers a meditation platform aimed at individuals who may be skeptical about traditional meditation practices. Founded in 2013, the company provides a mobile application that facilitates learning, practicing, and tracking meditation behaviors. The platform features expert-led courses, articles, and podcasts designed to foster meaningful changes in users' lives. Additionally, Ten Percent Happier publishes books that contain practical instructions for meditation, ensuring accessibility for a diverse audience. The company focuses on delivering a clear and straightforward approach to meditation, combining various multimedia resources to engage users effectively.

Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Mainspring designs and develops digital business strategies. The company provides consulting services focusing on digital technologies, business optimization, and technology enablement. Mainspring, formerly known as Mainspring Communications Inc., was founded in 1996 and is based in Cambridge, Massachusetts.

Twine Health, Inc. is a healthcare technology company that specializes in a cloud-based platform aimed at chronic disease management. The platform facilitates collaborative care by integrating tools for shared decision-making, self-tracking, and communication between patients and their healthcare providers. Patients can co-create personalized care plans with their care teams, which may include physicians, nurses, family members, and health coaches. This collaborative approach is designed to enhance patient engagement and self-efficacy, ultimately leading to better health outcomes and reduced healthcare costs. Established in 2012 and based in Cambridge, Massachusetts, Twine Health was developed at the MIT Medical Lab and operates as a subsidiary of Fitbit, Inc. since 2018.

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Digital Alloys develops high-speed, multi-metal additive manufacturing systems that print production quality parts, in almost any metal, at a fraction of the cost of other systems, making metal 3D metal printing economical for a greatly expanded mix of applications. Digital Alloys metal 3D printers have the unique ability to mix multiple metals in a solid part, enabling customers to push the limits of design and create new products with optimized thermal, electrical, magnetic, and mechanical properties. It was formed in January 2017 as a spinout from the NVLabs division of New Valence Robotics, Inc. (NVBOTS). The company is led by an experienced management team, and backed by Khosla Ventures. Digital Alloys is based in Burlington, Massachusetts.

Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics. The company offers a cloud database-as-a-service, known as SingleStore Managed Service, which enables analytics on the cloud of choice. Its flagship product, SingleStore DB, is a distributed SQL database that supports operational analytics on bare metal and hybrid cloud environments. SingleStore specializes in modernizing data platforms, securing government workloads, and facilitating IoT analytics, customer interactions, and risk management. It caters to a diverse range of industries, including financial services, media communications, energy, government, and retail. Founded in 2011 and headquartered in San Francisco, California, the company has additional offices in Seattle, Boston, Portland, Lisbon, and London. Initially known as MemSQL Inc., it rebranded to SingleStore, Inc. in October 2020.

Twine Health, Inc. is a healthcare technology company that specializes in a cloud-based platform aimed at chronic disease management. The platform facilitates collaborative care by integrating tools for shared decision-making, self-tracking, and communication between patients and their healthcare providers. Patients can co-create personalized care plans with their care teams, which may include physicians, nurses, family members, and health coaches. This collaborative approach is designed to enhance patient engagement and self-efficacy, ultimately leading to better health outcomes and reduced healthcare costs. Established in 2012 and based in Cambridge, Massachusetts, Twine Health was developed at the MIT Medical Lab and operates as a subsidiary of Fitbit, Inc. since 2018.

Editas Medicine is a clinical-stage biotechnology company based in Cambridge, Massachusetts, with an additional site in Boulder, Colorado. Founded in 2013, it is focused on discovering and developing innovative genome editing therapeutics to address a wide range of serious diseases. The company utilizes a proprietary platform based on CRISPR/Cas9 technology, which employs a protein-RNA complex to target and modify specific DNA sequences for therapeutic purposes. Editas Medicine aims to translate its advanced genome editing technologies into human therapeutics that can provide precise and corrective molecular modifications to treat genetic disorders. With a strong foundation of patent filings and intellectual property, the company is positioned to advance its early findings into viable treatments for various diseases at the genetic level.

SolidEnergy Systems Corp. develops and manufactures rechargeable lithium metal batteries primarily for applications in drones, wearables, smartphones, and electric vehicles. Founded in 2012 and based in Woburn, Massachusetts, the company focuses on producing high-performance lithium metal batteries and supplying essential materials, such as anodes and electrolytes, to major lithium-ion cell manufacturers. These materials can be integrated into existing manufacturing processes, allowing for scalability without significant infrastructure investments. SolidEnergy's pilot-scale production caters to prototype demonstrations and specialized aerospace markets, while its future growth is aimed at mainstream sectors like consumer electronics and electric vehicles. Additionally, the company is involved in developing AI-powered safety algorithms and recycling solutions, positioning itself as an integrated battery manufacturer with a commitment to innovation and sustainability.

Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

Quantopian, Inc. operates an online platform designed for the development and testing of quantitative trading algorithms. Founded in 2011 and based in Boston, Massachusetts, the platform offers tools and infrastructure that allow users to learn about quantitative finance, engage in community discussions, and explore algorithms shared by other members. Users can create and backtest their algorithms, review performance results and risk metrics, and trade their strategies. The company boasts a community of approximately 195,000 quants who collaborate and share insights. Additionally, select algorithm authors can license their algorithms to Quantopian, earning compensation based on performance. The firm provides capital, data, and resources to support its community in researching, coding, and executing algorithmic investing strategies.

Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. It offers personal security applications for both Android and iOS devices, focusing on mobile threat protection and theft prevention. Lookout's product suite also includes the Mobile Intelligence Center, which facilitates real-time access to mobile threat data, and an App Vetting API that secures enterprise and commercial app stores. The company aims to empower organizations to implement Bring Your Own Device (BYOD) policies, ensure compliance, and combat advanced mobile threats. Founded in 2005 and headquartered in San Francisco, California, Lookout has expanded its presence with offices in several global locations, including Boston, London, and Tokyo. It serves a diverse clientele, including enterprises, government agencies, and millions of consumers, by providing solutions that safeguard sensitive data across devices, applications, networks, and clouds.

EyeNetra, Inc. is a company that specializes in the development and manufacturing of eye diagnostics technology, including auto-refractors and lens-meters. Founded in 2011 and based in Somerville, Massachusetts, EyeNetra's platform allows users to conduct their own eye tests using smartphone-based technology. This innovative approach enables individuals to measure their refractive errors, such as nearsightedness, farsightedness, and astigmatism, while also providing eye care professionals with accurate diagnostic measurements for prescribing corrective lenses. The company's flagship products, including the NETRA autorefractor and lensometer, facilitate a straightforward and efficient testing process. Additionally, EyeNetra offers the Insight Portal, which enhances electronic medical record management and supports mobile clinics in delivering eye care services globally.

Ambri, Inc. is a company based in Marlborough, Massachusetts, focused on developing innovative electricity storage solutions through its liquid metal battery technology. Founded in 2010 and originally known as Liquid Metal Battery Corporation, Ambri aims to revolutionize grid-scale power storage by offering batteries that are low-cost, long-lasting, and capable of storing significant amounts of energy. These batteries are particularly suited for applications in renewable energy systems and grid stabilization. Ambri's technology is designed to enhance the reliability and efficiency of energy storage, with systems that can tolerate short circuits and other operational challenges, making them a robust choice for grid operators.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics. The company offers a cloud database-as-a-service, known as SingleStore Managed Service, which enables analytics on the cloud of choice. Its flagship product, SingleStore DB, is a distributed SQL database that supports operational analytics on bare metal and hybrid cloud environments. SingleStore specializes in modernizing data platforms, securing government workloads, and facilitating IoT analytics, customer interactions, and risk management. It caters to a diverse range of industries, including financial services, media communications, energy, government, and retail. Founded in 2011 and headquartered in San Francisco, California, the company has additional offices in Seattle, Boston, Portland, Lisbon, and London. Initially known as MemSQL Inc., it rebranded to SingleStore, Inc. in October 2020.

Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. It offers personal security applications for both Android and iOS devices, focusing on mobile threat protection and theft prevention. Lookout's product suite also includes the Mobile Intelligence Center, which facilitates real-time access to mobile threat data, and an App Vetting API that secures enterprise and commercial app stores. The company aims to empower organizations to implement Bring Your Own Device (BYOD) policies, ensure compliance, and combat advanced mobile threats. Founded in 2005 and headquartered in San Francisco, California, Lookout has expanded its presence with offices in several global locations, including Boston, London, and Tokyo. It serves a diverse clientele, including enterprises, government agencies, and millions of consumers, by providing solutions that safeguard sensitive data across devices, applications, networks, and clouds.

Quantopian, Inc. operates an online platform designed for the development and testing of quantitative trading algorithms. Founded in 2011 and based in Boston, Massachusetts, the platform offers tools and infrastructure that allow users to learn about quantitative finance, engage in community discussions, and explore algorithms shared by other members. Users can create and backtest their algorithms, review performance results and risk metrics, and trade their strategies. The company boasts a community of approximately 195,000 quants who collaborate and share insights. Additionally, select algorithm authors can license their algorithms to Quantopian, earning compensation based on performance. The firm provides capital, data, and resources to support its community in researching, coding, and executing algorithmic investing strategies.

GreenLight Biosciences, Inc. is a biotechnology company that specializes in developing RNA-based solutions for agricultural and pharmaceutical applications. Headquartered in Medford, Massachusetts, with an additional facility in North Carolina, the company focuses on producing high-quality RNA quickly and cost-effectively. GreenLight's technology platform facilitates the biological conversion of renewable substrates into valuable products, including chemicals and fuels. The company is actively involved in advancing vaccine development, particularly mRNA-based candidates aimed at preventing diseases such as SARS-CoV-2. Additionally, GreenLight engages in crop management and plant protection initiatives, contributing to sustainable agricultural practices and supporting the health of pollinators. Through its innovative approaches, GreenLight Biosciences aims to address global challenges in food security and public health.

Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. It offers personal security applications for both Android and iOS devices, focusing on mobile threat protection and theft prevention. Lookout's product suite also includes the Mobile Intelligence Center, which facilitates real-time access to mobile threat data, and an App Vetting API that secures enterprise and commercial app stores. The company aims to empower organizations to implement Bring Your Own Device (BYOD) policies, ensure compliance, and combat advanced mobile threats. Founded in 2005 and headquartered in San Francisco, California, Lookout has expanded its presence with offices in several global locations, including Boston, London, and Tokyo. It serves a diverse clientele, including enterprises, government agencies, and millions of consumers, by providing solutions that safeguard sensitive data across devices, applications, networks, and clouds.

Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. It offers personal security applications for both Android and iOS devices, focusing on mobile threat protection and theft prevention. Lookout's product suite also includes the Mobile Intelligence Center, which facilitates real-time access to mobile threat data, and an App Vetting API that secures enterprise and commercial app stores. The company aims to empower organizations to implement Bring Your Own Device (BYOD) policies, ensure compliance, and combat advanced mobile threats. Founded in 2005 and headquartered in San Francisco, California, Lookout has expanded its presence with offices in several global locations, including Boston, London, and Tokyo. It serves a diverse clientele, including enterprises, government agencies, and millions of consumers, by providing solutions that safeguard sensitive data across devices, applications, networks, and clouds.

Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. It offers personal security applications for both Android and iOS devices, focusing on mobile threat protection and theft prevention. Lookout's product suite also includes the Mobile Intelligence Center, which facilitates real-time access to mobile threat data, and an App Vetting API that secures enterprise and commercial app stores. The company aims to empower organizations to implement Bring Your Own Device (BYOD) policies, ensure compliance, and combat advanced mobile threats. Founded in 2005 and headquartered in San Francisco, California, Lookout has expanded its presence with offices in several global locations, including Boston, London, and Tokyo. It serves a diverse clientele, including enterprises, government agencies, and millions of consumers, by providing solutions that safeguard sensitive data across devices, applications, networks, and clouds.